Novo Nordisk
NVO
#81
Rank
HK$1.602 T
Marketcap
HK$360.73
Share price
-0.88%
Change (1 day)
-57.55%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Market capitalization of Novo Nordisk (NVO)

Market cap: HK$1.602 Trillion

As of December 2025 Novo Nordisk has a market cap of HK$1.602 Trillion. This makes Novo Nordisk the world's 81th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Novo Nordisk from 1996 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$1.602 T-46.24%
2024HK$2.981 T-17.23%
2023HK$3.602 T51.4%
2022HK$2.379 T19.62%
2021HK$1.988 T57.33%
2020HK$1.264 T16.67%
2019HK$1.083 T23.75%
2018HK$875.54 B-14.54%
2017HK$1.024 T40.29%
2016HK$730.27 B-38.14%
2015HK$1.180 T35.13%
2014HK$873.55 B11.33%
2013HK$784.65 B11.28%
2012HK$705.10 B36.09%
2011HK$518.10 B-1.43%
2010HK$525.62 B67.46%
2009HK$313.87 B24.67%
2008HK$251.77 B-23.05%
2007HK$327.19 B58.57%
2006HK$206.34 B46.08%
2005HK$141.25 B0.87%
2004HK$140.03 B27.74%
2003HK$109.62 B39.71%
2002HK$78.46 B-27.61%
2001HK$108.40 B12.44%
2000HK$96.41 B35.38%
1999HK$71.21 B-4.65%
1998HK$74.69 B-10.95%
1997HK$83.87 B54.63%
1996HK$54.23 B

End of Day market cap according to different sources

On Dec 9th, 2025 the market cap of Novo Nordisk was reported to be:

HK$1.610 Trillion
by Nasdaq info icon info icon
HK$1.602 Trillion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
HK$1.120 T-30.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$6.851 T 327.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$802.31 B-49.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$908.44 B-43.33%๐Ÿ‡ซ๐Ÿ‡ท France